Cargando…
The impact of metformin use on survival in prostate cancer: a systematic review and meta-analysis
BACKGROUND: Metformin has been implicated to reduce the risk of prostate cancer (PCa) beyond its glucose-lowering effect. However, the influence of metformin on prognosis of PCa is often controversial. RESULTS: A total of 13 cohort studies encompassing 177,490 individuals were included in the meta-a...
Autores principales: | Xiao, Yao, Zheng, Lei, Mei, Zubing, Xu, Changbao, Liu, Changwei, Chu, Xiaohan, Hao, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725033/ https://www.ncbi.nlm.nih.gov/pubmed/29245991 http://dx.doi.org/10.18632/oncotarget.22117 |
Ejemplares similares
-
Metformin use and survival outcomes in endometrial cancer: a systematic review and meta-analysis
por: Xie, Weimin, et al.
Publicado: (2017) -
Effects of metformin on survival outcomes of pancreatic cancer: a meta-analysis
por: Dong, Yi-Wei, et al.
Publicado: (2017) -
The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis
por: Tian, Shan, et al.
Publicado: (2017) -
Association between C-reactive protein and risk of schizophrenia: An updated meta-analysis
por: Wang, Zhichao, et al.
Publicado: (2017) -
Comparison of efficacy and tolerability of adjuvant therapy for resected high-risk stage III-IV cutaneous melanoma: a systemic review and Bayesian network meta-analysis
por: Ba, He, et al.
Publicado: (2023)